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Received December 26, 2011; accepted May 29, 2012AbstractAir leak syndrome includes pulmonary interstitial emphysema, pneumothorax, pneumomediastinum, pneumopericardium, pneumo-
peritoneum, subcutaneous emphysema, and systemic air embolism. The most common cause of air leak syndrome in neonates is inadequate
mechanical ventilation of the fragile and immature lungs. The incidence of air leaks in newborns is inversely related to the birth weight of the
infants, especially in very-low-birth-weight and meconium-aspirated infants. When the air leak is asymptomatic and the infant is not
mechanically ventilated, there is usually no specific treatment. Emergent needle aspiration and/or tube drainage are necessary in managing
tension pneumothorax or pneumopericardium with cardiac tamponade. To prevent air leak syndrome, gentle ventilation with low pressure, low
tidal volume, low inspiratory time, high rate, and judicious use of positive end expiratory pressure are the keys to caring for mechanically
ventilated infants. Both high-frequency oscillatory ventilation (HFOV) and high-frequency jet ventilation (HFJV) can provide adequate gas
exchange using extremely low tidal volume and supraphysiologic rate in neonates with acute pulmonary dysfunction, and they are considered to
have the potential to reduce the risks of air leak syndrome in neonates. However, there is still no conclusive evidence that HFOVor HFJV can
help to reduce new air leaks in published neonatal clinical trials. In conclusion, neonatal air leaks may present as a thoracic emergency requiring
emergent intervention. To prevent air leak syndrome, gentle ventilations are key to caring for ventilated infants. There is insufficient evidence
showing the role of HFOVand HFJV in the prevention or reduction of new air leaks in newborn infants, so further investigation will be necessary
for future applications.
Copyright  2012 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Respiratory failure is a major cause of morbidity and
mortality in neonatal critical care. During the past several
decades, there has been substantial advancement in the area of
neonatal respiratory care. The use of nasal continuous positive
airway pressure (NCPAP), conventional mechanical ventila-
tion (CMV), exogenous surfactant supplement, high-frequency* Corresponding author. Dr. Mei-Jy Jeng, Department of Pediatrics, Taipei
Veterans General Hospital, 201, Section 2, Shih-Pai Road, Taipei 112, Taiwan,
ROC.
E-mail address: mjjeng@vghtpe.gov.tw (M.-J. Jeng).
1726-4901/$ - see front matter Copyright  2012 Elsevier Taiwan LLC and the C
http://dx.doi.org/10.1016/j.jcma.2012.08.001oscillatory ventilation (HFOV), high-frequency jet ventilation
(HFJV), and inhaled nitric oxide have improved the general
outcome for neonates with severe respiratory failure of
different causes. However, air leak syndrome is still present in
critical neonates, even those neonates who have already
undergone these advanced ventilatory techniques.
Air leak syndrome is defined as that phenomenon when air
escapes from the tracheobronchial tree and collects in various
body spaces where it is not normally present. The escaping air
tracks along various pathways and localizes in different body
spaces leading to different types of air leaks, including pulmo-
nary interstitial emphysema (PIE), pneumothorax, pneu-
momediastinum, pneumopericardium, pneumoperitoneum,hinese Medical Association. All rights reserved.
Fig. 1. Illustrations of the air leaking from the tracheobronchial tree. 1,
pneumothorax; 2, pneumomediastinum; 3, pulmonary interstitial emphysema;
4, pneumopericardium; 5, subcutaneous emphysema; 6, pneumoperitoneum.
Arrows: directions of air leaks. (Modified from Professor Jen-Tien Wung,
Babies & Children’s Hospital of New York, Columbia University, New York,
NY, USA.)
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(Table 1).1,2 The pathways of air leaking from the tracheo-
bronchial tree are shown in Fig. 1.1
The most common cause of air leak syndrome is inadequate
mechanical ventilation on the fragile and immature lungs.
Therefore, air leak syndrome occurs more routinely during the
neonatal period than any other age,3 and the incidence is
inversely related to the birth weights of newborn infants. Air
leak syndromes occur in 1% to 2% of all newborns, and the
incidence rises to as high as 40% among infants on mechanical
ventilation in some situations and is the highest in the infants
with meconium aspiration syndrome.1 The common risk
factors of air leak syndrome are listed in Table 2.1,4,5
However, infants may still develop air leaks even without
mechanical ventilation. In the report of Migliori et al,6 10.3%
of infants treated with NCPAP developed pneumothorax.6 The
authors suggested that a marked increase in the requirement of
oxygen (FiO2 increase: 0.4 or above) during the first 24 hours
of NCPAP should be highly suggestive of the development of
a new pneumothorax.6 In addition, traumatic deliveries or
endotracheal intubation may atypically induce neonatal
tracheal injury or perforation, and that may cause subcuta-
neous emphysema and/or pneumomediastinum.7
Air leaks have been known as a risk factor in increasing the
mortality rate of infants with respiratory distress syndrome
(RDS).5,8 After review of 552 newborn infants with RDS, Sly
et al reported that air leaks developed in 22% of them,5 and
87% were under mechanical ventilatory treatment. The
mortality rate significantly increased from 12% in infants
without air leaks to 31% in infants with air leaks.5 Therefore,
prevention, early diagnosis and adequate management for the
development of air leak syndromes are crucial in caring
newborn infants with severe pulmonary dysfunction.
2. Classification2.1. PIETable 2
Risk factors of neonatal air-leak syndrome.
PrematurityPIE occurs when there is collection of gases outside the
normal air passages. There is an escape of air into pulmonary
interstitium, lymphatic and venous circulation, or secondary to
rupture at the junction of the bronchiole and alveolar duct. PIE
commonly occurs in conjunction with RDS, but other pre-
disposing etiological factors, such as meconium aspiration
syndrome or sepsis, may precipitate its occurrence. In the
general neonatal intensive care unit population, 2% to 3% of
all infants develop PIE. However, in premature infants withTable 1
Classification of air leak syndrome.
Pulmonary interstitial emphysema (PIE)
Pneumothorax
Pneumomediastinum
Pneumopericardium
Subcutaneous emphysema
Pneumoperitoneum
Systemic air embolismRDS, the incidence increases to 20% to 30%.9 High risk
premature infants with high ventilatory settings of CMV are
the major risk factors of PIE.
The diagnosis of PIE is mainly radiographic and patho-
logic. The anterior-posterior view of chest radiography may
show linear, oval, or spherical cystic air-containing spaces
(Fig. 2). The heart may become reduced in size, and lung
volume can be larger than its customary characteristic. It can
present localized or diffused distribution at the lung field, with
possible unilateral or bilateral involvement. Furthermore, it
can also be associated with the presence of pneumothorax. The
clinical manifestation of PIE is impairment of gas exchange
with hypercarbia and hypoxia, with an increased setting
necessary for ventilator support.Very low birth weight
Low Apgar score and need of resuscitation
Positive pressure ventilation
Use of high peak inspiratory pressure
Use of high tidal volume
Use of high inspiratory time
Respiratory distress syndrome
Meconium aspiration syndrome
Amniotic fluid aspiration
Pneumonia
Pulmonary hypoplasia
Fig. 2. A chest radiograph of a premature infant with respiratory distress
syndrome and pulmonary interstitial emphysema at the right lung field
(arrows). The lung is overexpanded to the eleventh rib.
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of the interstitial air pockets, loss of pulmonary compliance,
air embolus formations in pulmonary venous circulation,
pneumothorax, and the formation of bronchopulmonary
dysplasia/chronic lung disease.
If the patient is not critical, PIE is usually managed
conservatively, with gentle ventilation. The decubitus position
with the affected side down may be helpful. Sometimes,
selective intubation of the main bronchus on the uninvolved
side for at least 48 hours may also be beneficial.2 In addition,
a technique of single-lung ventilation using a Swan-Ganz
catheter to block the main bronchus on the disease side with
prominent PIE has been successfully used on neonates unre-
sponsive to conventional therapy.10 Lobectomy is rarely used
to treat the severely complicated PIE. Furthermore, HFOV or
HFJV are additional options that can be employed to reduce
the air-leak severity.2.2. PneumothoraxFig. 3. A chest radiograph of a premature infant with right tension pneumo-
thorax (arrows) and partial collapse of right lung. The mediastinum is shifted
to the left side.Pneumothorax refers to the presence of gas in the pleural
cavity between the visceral and parietal pleura, which results
in violation of the pleural space. It has been reported to have
an incidence of 6% to 10% in very-low-birth-weight (VLBW)
premature infants, and around 1% in term neonates.3,11e13
The initial clinical appearance of mild form pneumothorax
may be asymptomatic. As the condition progresses, infants
may suffer gradual deterioration of arterial blood gases, with
an increased oxygen or ventilator requirement. The infant may
appear agitated, or have unstable vital signs including an
initial increase in blood pressure. As the air leak progresses,
progressive respiratory distress, including rapid breathing,
grunting, nasal flaring, and chest wall retractions may become
significant. When tension pneumothorax occurs, there will be
acute and severe cyanosis, which combines with the onset ofacute bradycardia, hypotension, decreased pulse pressure and
peripheral perfusion, barrel shaped chest, and acute abdominal
distension.
Diagnosis of pneumothorax is usually made by radiography
(Fig. 3). However, a diagnosis of tension pneumothorax should
result in immediate emergency attention, since death can occur
even before diagnostic imaging can be completed. When
pneumothorax is suspected, anterioreposterior radiographic
views should be taken. Small pneumothoraces can be better
seen with lateral decubitus film, with the affected side up.
Sometimes, the costophrenic angle may be abnormally deep-
ened when the pleural air collects laterally, producing the deep
sulcus sign.14 Use of a chest transillumination test with high
intensity light may quickly help to establish a preliminary
diagnosis in neonates, and excessive light can be transmitted at
the affected side (Fig. 4).1,15
Medical management of pneumothorax depends on its
severity. When patients are asymptomatic and not on ventilator
support, there is no need for specific management. In full-term
neonates, not in premature infants, with small uncomplicated
pneumothorax, a support of 100% oxygen for nitrogen
washout may improve the resolution of pneumothorax in cases
without mechanical ventilation. Emergent thoracentesis with
needle aspiration is necessary to treat a symptomatic pneu-
mothorax. The location of the aspirated site is at the third
intercostal space in the midclavicular or anterior axillary line.
Use of a 24-gauge angiocatheter or a scalp vein needle
attached to 20 mL syringe with a stopcock is suggested for the
emergent aspiration of leaked air from the pleural cavity.16 In
addition, it has been reported to treat expectantly without
initial chest-tube placement in some ventilated neonates with
pneumothorax if the vital signs are stable.17
Chest tube insertion for definitive drainage is usually
necessary in the case of tension pneumothorax and a pneu-
mothorax that develops in a mechanically ventilated infant. A
Fig. 4. Positive transillumination test on a premature infant with right pneu-
mothorax. The right pleural cavity is transilluminated with bright red light.
(Courtesy of Professor Jen-Tien Wung, Babies & Children’s Hospital of New
York, Columbia University, New York, NY, USA.)
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insertion site can be at the midclavicular line of the second to
third intercostal spaces or at the anterior to midaxillary line of
the fourth to sixth intercostal spaces.16,18 The chest tube can
be connected with a negative pressure of 10 to 15 cmH2O
suctioning for promoting adequate drainage.19 A chest radio-
graph to confirm the lung expansion condition and chest tube
position is necessary after the procedures are completed. If
there are any continuous air leaks with water vapor in the chest
tube, lung perforation from chest tube placement or broncho-
pleural fistula from endotracheal suctioning should be
considered. In these conditions, one-lung ventilation may be
required, with thoracotomy and suturing of the broncho-
pleural fistula. After cessation of air leaks, place the chest
tube under water seal for 24 hours. If there is no reac-
cumulation of air, remove chest tube during expiration if
breathing spontaneously or during inspiration if on the venti-
lator. A further radiological confirmation after removal of the
chest tube is necessary. In addition, percutaneous small bore
pigtail catheters (8e10F) or a large size (18-gauge) venous
catheter have been used for air drainage in neonates, but the
potential risks of pulmonary perforation and catheter blockage
are greater in premature infants.20e232.3. PneumomediastinumFig. 5. A chest radiograph of a newborn infant with pneumopericardium
(arrows). (Courtesy of Professor Jen-Tien Wung, Babies & Children’s Hospital
of New York, Columbia University, New York, NY, USA.)Pneumomediastinum is a condition where air leaks into the
mediastinal space. The diagnosis is made on a chest radio-
graph, with a noted presence of hyperlucent areas around the
heart border and between the sternum and the heart border.15 If
it is an isolated problem, most cases are asymptomatic and
may resolve spontaneously under gentle respiratory care. Thepatient should be closely observed for the possibility of other
air leaks, especially pneumothorax.
However, collection of any considerable volume of air in
the mediastinal space may result in tachypnea and hypoxia.
Distant heart sound may be found while confirming this with
a stethoscope. Furthermore, bulging of the midthoracic area,
distended neck veins, and low blood pressures may occur if
the amount of air leak in the mediastinal space is serious
enough to induce tamponade of the systemic and pulmonary
veins.15 When these conditions happen, pneumopericardium
may also occur and be fatal without adequate decompression.2.4. PneumopericardiumPneumopericardium is a rare condition caused by air in the
pericardial space. In severe condition, it can cause cardiac
tamponade that is life-threatening. Pneumopericardium typi-
cally occurs in a mechanically ventilated preterm infant with
severe RDS who also has pneumothorax and/or PIE.
The onset of pneumopericardium is an abrupt onset of
hemodynamic compromise due to cardiac tamponade.
Tachycardia and a narrowed pulse pressure may be followed
by bradycardia, hypotension, deteriorated respiratory distress,
and cyanosis. The heart sound may be distant or difficult to be
heard. The electrocardiogram may show low voltages with
a small QRS complex.
The diagnosis of pneumopericardium is confirmed by chest
radiograph. It may show a gas shadow surrounding the heart
(Fig. 5).1 In life-threatening situations in which pneumo-
pericardium is strongly suspected, the diagnosis can be
confirmed by a therapeutic pericardiocentesis.
The management of pneumopericardium is mainly close
monitoring if it is asymptomatic. Ventilator adjusting to
decrease pressure is necessary to minimize the severity of air
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infants for both diagnostic and therapeutic purposes.2.5. PneumoperitoneumPneumoperitoneum is an uncommon type of air leak. It
occurs when extrapulmonary air gets into the peritoneal cavity.
The diagnosis is typically made after review of an abdominal
radiograph, and usually has little clinical significance. The
abdominal x-ray may reveal a dark layer over the abdomen
obscuring the normal bowel pattern. It must be differentiated
from intraperitoneal air due to a perforated intra-abdominal
organ. If it results from ruptured viscus, immediate surgical
intervention is required. However, abdominal air of intratho-
racic origin usually requires observation only.2.6. Subcutaneopus emphysemaSubcutaneous emphysema is characterized by crepitus on
physical examination by palpation. It typically occurs in the
face, neck, axillary, or supraclavicular regions. On the radio-
graphs, disseminated leaked air can be observed in the
subcutaneous tissue (Fig. 6).1 It is usually of no clinical
significance, although large amount of air may cause tracheal
compromise. Management is mainly observation and
decreasing the ventilatory settings for its resolution.2.7. Systemic air embolismIn systemic air embolism, the air rupturing from the alveoli
enters directly into the pulmonary capillaries, after which the
infant develops abrupt cyanosis and circulatory collapse. Air
popping in the heart may be audible with a stethoscope. Air
admixed with blood may also be withdrawn from the umbilical
arterial catheter sampling. There is no specific treatment and
this condition is invariably fatal.1Fig. 6. A chest radiograph of a newborn infant with diffuse subcutaneous
emphysema (arrows). There is leaked air disseminating in the subcutaneous
tissue of neck, shoulder, chest wall, and bilateral axillary area.3. Prevention of air-leak syndrome3.1. Gentle ventilationGentle ventilation is the key to prevent air leak syndrome.
In addition, gentle resuscitation in the delivery room is also
important to reduce the incidence of air leak syndrome in
high-risk newborns.7,24
The goal of mechanical ventilation is to achieve and
maintain adequate pulmonary gas exchange, minimize the risk
of lung injury, reduce patient work of breathing, and optimize
the patient’s comfort. The concept of ventilator-induced lung
injury (VILI) was described by Hudson in 1999.25 Volutrauma
with the increase in vascular filtration and stress fractures of
capillaries, epithelium, and basement membranes and bio-
trauma with increased proinflammatory cytokines and subse-
quent inflammatory reactions are the main problems (Fig. 7).
Air leaks, pulmonary fibrosis and recurrent pulmonary infec-
tions may occur and cause mortality or chronic lung disease.
Premature infants with antecedent lung injury are more prone
to VILI. Gentle ventilation with the concept of permissive
hypercapnia, low tidal volumes, low peak inspiratory pressure,
high rate, and low inspiratory time (IT) all may be helpful in
reducing air-leak syndrome.26e28 Permissive hypercapnia and
judicious use of NCPAP have been used in caring for high-risk
newborn infants for a long time, with a relatively low inci-
dence of air leaks and bronchopulmonary dysplasia.1,29,30
There have been clinical trials further examining the concept
of permissive hypercapnia in premature infants,26,27 which
found that the need for mechanical ventilation at 36 weeks
post-conceptional age can be reduced from 16% to 1% in
premature infants with permissive hypercapnia (maintaining
PaCO2 >52 mmHg).
27
Kamlin conducted a meta-analysis on the role of IT in
mechanically ventilated infants. Five studies (694 infants)
were analyzed, and it was concluded that long IT (0.5
seconds) is significantly associated with the occurrence of air
leaks [risk ratio (RR) 1.56, 95% confidence interval (CI)
1.25e1.94] and increased mortality rate (RR 1.26, 95% CIFig. 7. Simplified injury mechanism of ventilator-induced lung injury.
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pulmonary dysplasia, although all of the included studies were
conducted prior the use of antenatal steroids, postnatal
surfactant and HFOV. Consequently, there may be some
difference currently.
In addition, Klinger et al has reported that pneumothorax in
VLBW infants is associated with factors present on the day of
pneumothorax and not with initial ventilation variables or
initial severity of lung disease. They suggested that vigorous
control of ventilation, including optimizing positive end-
expiratory pressure and minimizing peak inspiratory pressure
and the number of suction procedures, is required to decrease
the risk of pneumothorax in VLBW infants.11
In the meta-analysis of Steven et al (6 studies, 664 partic-
ipants), the use of early surfactant administration with brief
ventilation (rapid extubation to NCPAP) may reduce the risk
of air leak syndrome (RR 0.52, 95%CI 0.28e0.96).32
In considering of the role of continuous distending pressure
(CDP) in RDS, a systemic review by Ho et al summarized that
the use of CDP either as CPAP by mask, nasal prong, naso-
pharyngeal tube, or endotracheal tube, or continuous negative
pressure via a chamber enclosing the thorax and lower body is
associated with an increased rate of pneumothorax (summary
RR 2.36, 95%CI 1.25e5.54). Nonetheless, it did decrease the
rate of failed treatment and overall mortality.33 Therefore,
a judicious use of CDP is crucial in treating premature infants.3.2. Role of high-frequency ventilationsHigh-frequency ventilations with extremely low tidal
volumes and supraphysiologic rates have been successfully
demonstrated to reduce lung injury in experimental models of
acute lung injury.34,35 Both HFOV and HFJV have been
applied on neonates with acute pulmonary dysfunction.19
3.2.1. HFOV
In 1972, Lunkenheimer et al36 first discovered that HFOV
could maintain normocapnia by oscillating small volumes of
air into animals’ lung at a frequency of 23-40 Hz. The first
report of HFOV use as applied to humans was published in
1981 by Marchak et al.37 Since then, several clinical trials
investigating the role of HFOV to treat surfactant-deficient
RDS in premature infants or other types of acute lung injury
(ALI) or acute respiratory distress syndrome (ARDS) have
taken place. Currently, there is dramatic increase in clinical
use of HFOV in rescuing infants suffering from respiratory
failure.19,38
HFOV needs an electromagnetically driven diaphragm or
a piston pump to generate oscillating movements of dia-
phragm, and induces active inspirations and expirations. The
oscillators can deliver extremely low tidal volumes (1e3 mL/
kg) and very high ventilatory rates (210e900 breaths/min).19
It is able to ventilate patients with adequate lung volume
and minimize the risks of volutrauma and atelectrauma,39,40 so
HFOV is also believed to reduce the risk of air leak
syndrome.16,35,41,42 Ultimately, the use of HFOV has been
determined to be an ideal lung-protective ventilator strategy.39There have been various studies that indicate that HFOV can
reduce VILI compared with CMV using conventional venti-
lator strategies (nonprotective ventilation strategies), and even
when CMV is used with a protective ventilation strategy.39
Analyzing the clinical role of HFOV on air leak syndrome,
the results did not completely support the proposed beneficial
effects. In treating premature infants with RDS, HFOV has
also been used as elective or rescue therapies. A meta-analysis
involving 10 trials (3229 participants) by Cools et al demon-
strated that elective HFOV did not decrease the incidence of
gross (RR 1.08, 95%CI 0.88e1.32) or any pulmonary leak
(RR 1.15, 95%CI 1.00e1.33) in premature infants with
RDS.43 In addition, Cools et al published a systemic review on
elective HFOV therapy in premature infants involving 17
eligible studies (3652 infants), all with publication dates
between 1989 and 2008.44 Among them, 12 trials (2766
infants) reported data showing any pulmonary air leaks and
revealed a small but significant increase in the HFOV group
(RR 1.19, 95%CI 1.05e1.34; Table 3).38,44e64 In addition, 10
trials (1829 infants) revealed a non-significant trend toward an
increase in HFOV group (RR 1.30, 95%CI 0.99e1.70]) in the
analysis of gross pulmonary air leak (pneumomediastinum or
pneumothorax; Table 3).44 The limitations of this review were
that the HFOV ventilators and the results among trials were
quite variable. Furthermore, no clear overall benefit or harm
resulting from HFOV was demonstrated by these clinical
trials.
In the systemic review of rescue HFOV therapy in prema-
ture infants with severe respiratory dysfunction by Bhuta and
Henderson-Smartb, only one randomized controlled trial of
182 infants was chosen,47 and that was published in 1993 by
the HIFO study group.48 This single trial demonstrated that
any new pulmonary air leak was significantly reduced in
HFOV treated infants than the use of CMV (RR 0.73, 95%CI
0.55e0.96; Table 3), but there was no significant difference in
the rate of PIE or of gross pulmonary air leak (RR 0.80, 95%
CI 0.45e1.42; Table 3).44,48 However, the limitation of this
review is that only one trial was undertaken, and that the
majority of enrolled infants were not treated with exogenous
surfactant.
A recent systemic review of full-term or near-term infants
(born at 35 weeks gestational age or more) with severe
respiratory failure done by Henderson-Smart et al included 2
clinical trials published in 1994 (79 infants, rescue therapy)
and 2005 (118 infants, elective therapy; Table 3).38 Neither
study described any significant difference in the risk of air
leaks between HFOV and CMV.38
Therefore, there is lack of evidence to support the routine
use of HFOV instead of CMV to reduce air leaks in newborn
infants with acute pulmonary dysfunction. Further trials on
more risky newborn infants, and comparing the different
therapeutic strategies for HFOV and CMV may be necessary
for future clinical application.
3.2.2. HFJV
The HFJV procedure requires use of a special endotracheal
tube with a side lumen to deliver the jet ventilations (240e660
Table 3
Summary of the relative risk (RR) of pulmonary air leak in published data (HFOV vs. CMV).
Author/year(Reference) Air leak HFOV
n/N (%)
CMV
n/N (%)
RR [95% CI] HFOV ventilator
type
At or near term
Rescue
Clark 199438,46 AAL 4/39 (10) 6/40 (15) 0.68 [0.21e2.24] B
Elective
Rojas 200538,45 AAL 2/54 (4) 1/64 (2) 2.37 [0.22e25.43] B
Preterm
Rescue
HIFO 199347,48 AAL 39/83 (47) 56/87 (64) 0.73 [0.55e0.96]a B
GAL 16/83 (19) 21/87 (24) 0.80 [0.45e1.42] B
Elective
HIFI 198944,49 AAL 148/327 (45) 131/346 (38) 1.20 [1.00e1.43] A
Clark 199244,50 AAL 18/37 (49) 10/28 (36) 1.36 [0.75e2.47] B
GAL 14/37 (38) 8/28 (29) 1.32 [0.65e2.71] B
Ogawa 199344,51 AAL 4/46 (9) 6/46 (13) 0.67 [0.20e2.21] A
Gerstman 199644,52 AAL 8/64 (12.5) 11/61 (18) 0.69 [0.30e1.61] B
Rettwitz-Volk 199844,53 AAL 7/46 (15.2) 7/50 (14) 1.09 [0.41e2.86] G
GAL 3/46 (7) 5/50 (10) 0.65 [0.17e2.58] G
Thome 199844,54 AAL 59/140 (42) 44/144 (31) 1.38 [1.01e1.89]a C
GAL 20/140 (14) 11/144 (8) 1.87 [0.93e3.76] C
Plavka 199944,55 AAL 3/21 (14) 3/20 (15) 0.95 [0.22e4.18] B
GAL 1/21 (5) 2/20 (10) 0.48 [0.05e4.85] B
Moriette 200144,56 GAL 7/139 (5) 4/134 (3) 1.69 [0.51e5.63] D
Courtney 200244,57 GAL 32/244 (13) 35/254 (14) 1.01 [0.64e1.59] B
Johnson 200244,58 AAL 64/400 (16) 72/397 (18) 0.88 [0.65e1.20] B,E,F
Craft 200344,59 AAL 8/22 (36) 6/24 (25) 1.45 [0.60e3.53] C
Schreiber 200344,60 AAL 47/102 (46) 29/105 (28) 1.67 [1.15e2.43]a B
GAL 17/102 (17) 10/105 (10) 1.75 [0.84e3.64] B
Van Reempts 200344,61 AAL 24/147 (16) 16/153 (10) 1.56 [0.86e2.82] B,C
GAL 11/147 (7) 7/153 (5) 1.64 [0.65e4.10] B,C
Vento 200544,62 GAL 2/20 (10) 1/20 (5) 2.00 [0.20e20.33] F
Dani 200644,63 GAL 0/13 (0) 1/12 (8) 0.31 [0.01e6.94] B
Lista 200844,64 AAL 1/19 (5) 1/21 (5) 1.11 [0.07e16.47] F
Sum of AAL (12 trials)44 AAL 391/1371 (29) 336/1395 (24) 1.19 [1.05e1.34]a
Sum of GAL (10 trials)44 GAL 107/909 (12) 82/920 (9) 1.30 [0.99e1.70]
AAL¼ any air leak; GAL¼ gross air leak (excluding pulmonary interstitial emphysema alone); CMV¼ conventional mechanical ventilation; HFOV¼ high-
frequency oscillatory ventilation.
HFOV ventilator: A¼Hummingbird; B¼ SensorMedics 3100A; C¼ Infant Star; D¼Dufour-OHF1; E¼ SLE-2000HFO; F¼Dra¨ger Babylog 8000; G¼ Stephan
SHF3000 piston oscillator.
a Presence of significant difference ( p< 0.05) between HFOV and CMV group.
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flow from a conventional ventilator. So, CMV can be delivered
in conjunction with HFJV.65e67 The exhalation phases are
passive, and the major difference between HFJV and HFOV is
the inspiratory to expiratory ratios (I/E). The I/E in HFOV may
be fixed at 1:1 or adjustable on the inspiratory percentage
(usually 33%); in HFJV, the I/E is usually set at 1:6. Theo-
retically, the very low I/E makes it effective in managing
patients with PIE.65,66
In 1991, Keszler et al reported that HFJV could result in
improved ventilation at lower peak and mean airway pres-
sures, and more rapid radiographic improvement of PIE in
neonatal infants than CMV.65 This study was also the only
study (144 infants) included in the meta-analysis of Cochrane
database systemic review in 2006 for rescue use of HFJV in
preterm infants.66 However, there was no significant difference
between CMV and HFJV in the outcome analysis of new air
leaks. In an earlier meta-analysis of elective HFJV use forRDS in 248 preterm infants in 2000, three trials were included,
but there was also no significant difference between HFJV and
CMV in the outcome analysis of air leaks.67
In conclusion, neonatal air leak syndrome may be asymp-
tomatic, or present as an emergency that requires the attention
of trained care providers available in neonatal intensive care
units on a continuing basis. To reduce the risk of air leak
syndrome, gentle ventilations are the key to caring for
mechanically ventilated infants. The role that HFOV and
HFJV may play in preventing new air leaks in newborn infants
remains unsettled due to a lack of dispositive evidence, so
further investigation is necessary to best ascertain future
clinical applications.
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